Hospital at home care in chronic obstructive pulmonary disease (COPD): a study on the associated health economy and disease-related quality of life

ISRCTN ISRCTN36101176
DOI https://doi.org/10.1186/ISRCTN36101176
Protocol serial number N/A
Sponsor Regional Authorities for Hospital Care, South-East Norway (Helse Sør-Øst Norge RHF) (Norway)
Funders Regional Authorities for Hospital Care, South-Eastern Norway (Helse Sør-Øst RHF) (Norway), The Norwegian Research Council (Norsk Forskningsråd) (Norway)
Submission date
17/01/2008
Registration date
20/03/2008
Last edited
20/03/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Torbjørn Haugen
Scientific

HØKH
Akershus Unversitetssykehus HF
Sykehusveien 27
Lørenskog
1478
Norway

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleHospital at home care in exacerbations of chronic obstructive pulmonary disease (COPD)
Study acronymHBKOLS
Study objectivesPrevious studies in other countries indicate that home treatment with nursing support is suitable in selected patients with exacerbations of chronic obstructive pulmonary disease (COPD), presenting to hospital as an emergency.

Hypothesis:
Three days of hospital at home care in mild to moderate exacerbations of COPD is cost saving in the Norwegian health care system and implies at least the same level of disease-related quality of life as traditional hospital care.
Ethics approval(s)Ethics approval received from the Regional Ethics Committee for Medical Research of East Norway on the 21st December 2007 (ref: 1.2007.2613).
Health condition(s) or problem(s) studiedChronic obstructive pulmonary disease (COPD)
InterventionHospital-at-home group (experimental arm):
Three days organised by the hospitals with specially trained nurses. In the same period of time the patient can contact the lung department at the hospital by phone for advice. Thereafter, if medical follow up is needed, by the primary care system (primary physician, home nurses).

Hospital group (control arm):
As long as needed in the hospital. Thereafter, if needed, by the primary care personnel as for the other group. In contrast to the other group, the length of the in-hospital treatment is not specified.

Follow up for both groups: After 6 weeks, 6 months and 12 months.
Intervention typeOther
Primary outcome measure(s)

Health economy measures.

Time points: 6 weeks, 6 months and 12 months.

Key secondary outcome measure(s)

1. Level of disease-related quality of life, measured with the St. George Respiratory Questionnaire
2. Mental health (level of anxiety and depression), measured with the Hospital Anxiety and Depression Scale

Time points: 6 weeks, 6 months and 12 months.

Completion date01/03/2010

Eligibility

Participant type(s)Patient
Age groupSenior
SexAll
Target sample size at registration180
Key inclusion criteria1. Patients under 80 years of age, either sex, with exacerbation of COPD
2. Presenting to the hospital as an emergency
Key exclusion criteria1. Serious exacerbation including impending or actual respiratory failure
2. Serious comorbidity
Date of first enrolment01/03/2008
Date of final enrolment01/03/2010

Locations

Countries of recruitment

  • Norway

Study participating centre

HØKH
Lørenskog
1478
Norway

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
BMC - Part of Springer Nature Springer Nature